查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1428163

2024 年靜脈 (IV) 水化療法全球市場報告

Intravenous (IV) Hydration Therapy Global Market Report 2024
出版日期: 按訂單生產 | 出版商: The Business Research Company | 英文 175 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

靜脈（IV）水化療法市場規模預計在未來幾年將顯著成長。預計到 2028 年將以 8.8% 的複合年成長率 (CAGR) 成長至 39.2 億美元。預測期內的預期成長是由靜脈補水療法轉向以消費者為中心的個人化、將其融入企業健康計劃、更加重視預防性健康措施以及健身和健康旅遊領域的擴張所推動的。這是多種因素造成的，其中包括人口老化導致的需求增加。在此期間預計的主要趨勢包括道德和永續採購慣例、結合靜脈水化療法的整體健康靜修的出現，以及建立水化酒吧和休息室以滿足健康需求；其中包括更加關注與水化療法相結合的心理健康服務。這些趨勢將在預測期內對市場產生重大影響並塑造其軌跡。

慢性病盛行率的快速成長預計將推動靜脈（IV）水化治療市場的顯著成長。這種治療方法包括靜脈注射維生素和必需營養素，為對抗慢性疾病的個體提供顯著的能量提升。截至 2022 年 9 月，世界衛生組織報告稱，每年有 4,100 萬人死亡，佔全球非傳染性疾病 (NCD) 或慢性病死亡人數的 74%。其中，1,790萬人死於心血管疾病，930萬人死於癌症，410萬人死於慢性呼吸道疾病，200萬人死於糖尿病。這種慢性疾病盛行率的上升是推動靜脈（IV）水化治療市場成長的關鍵因素。

老齡化人口的持續成長預計將進一步推動靜脈（IV）水化治療市場的擴張。人口老化的特徵是社會中老年人比例不斷增加，靜脈補水療法可以有效解決這一問題，該療法可以對抗脫水並提供必需的營養，從而促進整體健康和福祉。世界衛生組織 2022 年 10 月發布的預測顯示，到 2030 年，全球六分之一的人口將超過 60 歲。在此期間，60歲及以上人口的比例預計將從2020年的10億增加到14億。此外，到 2050 年，全球 60 歲及以上人口預計將增加一倍，達到 21 億。因此，人口老化的加劇是靜脈（IV）水化治療市場的關鍵促進因素。

目錄

第1章執行摘要

第2章 市場特點

第3章 市場趨勢與策略

第4章宏觀經濟情景

  • 高通膨對市場的影響
  • 烏克蘭與俄羅斯戰爭對市場的影響
  • COVID-19 對市場的影響

第5章世界市場規模與成長

  • 全球靜脈 (IV) 水化治療市場促進因素與限制
    • 市場驅動力
    • 市場限制
  • 2018-2023 年全球靜脈 (IV) 水化治療市場規模、表現和成長
  • 全球靜脈 (IV) 水化治療市場規模及成長預測，2023-2028 年、2033 年

第6章市場區隔

  • 全球靜脈 (IV) 水化治療市場，按服務、績效和預測細分，2018-2023、2023-2028、2033
  • 免疫增強劑
  • 能量助推器
  • 護膚
  • 偏頭痛
  • 其他服務
  • 全球靜脈 (IV) 水化治療市場，按成分、表現和預測細分，2018-2023、2023-2028、2033
  • 藥用
  • 非藥用的
  • 全球靜脈 (IV) 水化治療市場，按最終用戶細分、績效和預測，2018-2023、2023-2028、2033
  • 醫院和診所
  • 健康中心和水療中心
  • 家庭治療
  • 其他最終用戶

第 7 章 區域與國家分析

  • 全球靜脈 (IV) 水化治療市場，按地區、績效和預測，2018-2023、2023-2028、2033
  • 全球靜脈 (IV) 水化治療市場，按國家、績效和預測，2018-2023、2023-2028、2033

第8章亞太市場

第9章 中國市場

第10章 印度市場

第11章 日本市場

第12章 澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章 西歐市場

第16章英國市場

第17章 德國市場

第18章 法國市場

第19章 義大利市場

第20章 西班牙市場

第21章 東歐市場

第22章 俄羅斯市場

第23章 北美市場

第24章美國市場

第25章加拿大市場

第26章 南美洲市場

第27章 巴西市場

第28章 中東市場

第29章 非洲市場

第30章 競爭形勢及公司概況

  • 靜脈（IV）水化治療市場的競爭形勢
  • 靜脈（IV）水化治療市場公司概況
    • Revitalist
    • JW Life Science Corporation
    • NextGen Healthcare
    • B. Braun Medical Inc.
    • Pfizer Inc.

第31章 其他大型創新公司

  • Fresenius Kabi AG
  • Liquid IV
  • Medtronic Plc.
  • Drip Hydration
  • Amanta Healthcare Ltd.
  • Becton Dickinson and Company
  • Elixir
  • Baxter International Inc.
  • Otsuka Pharmaceutical Co. Ltd.
  • Sippex IV bag
  • REVIV
  • Braun Melsungen AG
  • The IV Doc Inc.
  • Terumo Medical Corporation
  • Grifols SA

第32章競爭基準化分析

第 33 章. 競爭對手儀表板

第34章 重大併購

第35章 未來前景與可能性分析

第36章附錄

簡介目錄
Product Code: r14007

Intravenous (IV) hydration therapy is a simple medical procedure involving the insertion of a small IV into the arm to deliver fluids directly into the bloodstream. This method facilitates faster absorption of nutrients, fluids, medications, and blood, aiding in the body's treatment and recovery process by utilizing the circulatory system.

The primary service categories within intravenous (IV) hydration therapy encompass immune boosters, energy boosters, skin care treatments, migraine relief, and other specialized therapies. Immunity boosters are products designed to enhance the immune system and reduce susceptibility to illnesses. These products come in medicated and non-medicated forms and cater to diverse end-users, including hospitals and clinics, wellness centers and spas, home healthcare services, and other relevant facilities.

The intravenous(IV) hydration therapy market research report is one of a series of new reports from The Business Research Company that provides intravenous(IV) hydration therapy market statistics, including intravenous(IV) hydration therapy industry global market size, regional shares, competitors with an intravenous(IV) hydration therapy market share, detailed intravenous(IV) hydration therapy market segments, market trends, and opportunities, and any further data you may need to thrive in the intravenous(IV) hydration therapy industry. This intravenous (IV) hydration therapy market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The intravenous (iv) hydration therapy market size has grown strongly in recent years. It will grow from $2.57 billion in 2023 to $2.8 billion in 2024 at a compound annual growth rate (CAGR) of 8.7%. The growth observed in the historical period can be attributed to several factors including advancements in medical treatments and procedures, the use of intravenous (IV) hydration therapy for enhancing athletic and sports performance, clinical management of dehydration in various health conditions, aiding in recovery from illnesses, and the emergence of mobile and concierge services offering this therapy. These factors collectively contributed to the expansion of the IV hydration therapy market during the historic period.

The intravenous (iv) hydration therapy market size is expected to see strong growth in the next few years. It will grow to $3.92 billion in 2028 at a compound annual growth rate (CAGR) of 8.8%. The anticipated growth in the forecast period is expected to stem from various factors, including a shift towards consumer-centric personalization of IV hydration therapy, its integration into corporate wellness programs, increased emphasis on preventive health measures, expansion within the fitness and wellness tourism sectors, and heightened demand driven by an aging population. Key trends projected for this period encompass ethical and sustainable sourcing practices, the emergence of holistic health retreats incorporating IV hydration therapy, the establishment of hydration bars and lounges catering to wellness needs, and a growing focus on mental wellness in conjunction with hydration therapy services. These trends are poised to significantly impact the market and shape its trajectory in the forecasted period.

The anticipated surge in the prevalence of chronic diseases is poised to drive significant growth in the intravenous (IV) hydration therapy market. This therapeutic approach involves the administration of vitamins and essential nutrients intravenously, offering a substantial energy boost to individuals grappling with chronic diseases. As of September 2022, the World Health Organization reported a staggering 41 million annual deaths, accounting for 74% of fatalities attributed to non-communicable diseases (NCDs) or chronic ailments globally. Notably, cardiovascular diseases contributed to 17.9 million deaths, cancer to 9.3 million deaths, chronic respiratory diseases to 4.1 million deaths, and diabetes to 2.0 million deaths. This escalation in chronic disease prevalence is a pivotal factor propelling the growth of the intravenous (IV) hydration therapy market.

The continual rise in the aging population is poised to further fuel the expansion of the intravenous (IV) hydration therapy market. Characterized by an increasing proportion of elderly individuals in society, the aging population is effectively addressed by IV hydration therapy to combat dehydration and provide essential nutrients, thereby enhancing overall health and well-being. Projections from the World Health Organization in October 2022 indicated that, by 2030, one out of every six individuals globally would be 60 years old or older. The proportion of the population aged 60 and over is expected to rise from 1 billion in 2020 to 1.4 billion during this period. Furthermore, the global population of individuals aged 60 and older is anticipated to double, reaching 2.1 billion by 2050. Consequently, the increasing aging population stands as a significant driver for the intravenous (IV) hydration therapy market.

The intravenous (IV) hydration therapy market is experiencing a notable trend towards product innovation, with major companies leveraging new technologies to maintain their market positions. An illustrative example occurred in September 2022 when Concierge Medical Consultants Inc, a Canada-based group of board-certified physicians specializing in private, discreet, and personalized healthcare, introduced Intravenous Vitamin Therapy (IV Therapy) to its services in Toronto and Vancouver. This addition included a novel IV hydration service featuring six variations of Vitamindrip products such as hydration, recovery, energy, cosmetics, diet and detox, and immune boost. The scientifically formulated Vitamin drip, administered intravenously, effectively addresses dehydration and various disorders such as migraines, acute muscle spasms, asthma, upper respiratory tract infections, chronic sinusitis, and seasonal allergic rhinitis.

Major players in the intravenous (IV) hydration therapy market are directing their efforts towards the development of sterile solutions, particularly CBD isolate, to meet the growing demand for CBD infusion and gain a competitive edge. CBD isolate, recognized as the purest form of cannabidiol, contains no additional cannabinoids or plant compounds. In a notable development in September 2023, Apex Labs CBD, a US-based company offering a diverse range of high-quality CBD products, launched Pico IV, a CBD isolate specifically designed for intravenous (IV) therapy. Pico IV's sterile solution ensures safe intravenous use, catering to the increasing demand for CBD infusion in the rapidly expanding IV hydration therapy market. Distinguished by the reduction of the CBD molecule size to a picometer, Pico IV offers maximum absorption and is exclusively available for online purchase to licensed IV therapy providers.

In May 2022, Fresenius Kabi AG, a prominent healthcare company based in Germany, completed the acquisition of Ivenix Inc. The financial details of the transaction were undisclosed. This strategic move by Fresenius Kabi AG is aimed at establishing a comprehensive and innovative portfolio of top-tier infusion treatment solutions specifically tailored for the American market. Ivenix Inc., based in the United States, is recognized for pioneering a new generation of intravenous (IV) hydration therapy. The acquisition aligns with Fresenius Kabi AG's commitment to enhancing and diversifying its offerings in the healthcare sector, particularly in the realm of infusion treatments.

Major companies operating in the intravenous (iv) hydration therapy market report are Revitalist, JW Life Science Corporation, NextGen Healthcare, B. Braun Medical Inc., Pfizer Inc., Fresenius Kabi AG, Liquid IV, Medtronic Plc., Drip Hydration, Amanta Healthcare Ltd., Becton Dickinson and Company, Elixir, Baxter International Inc., Otsuka Pharmaceutical Co. Ltd., Sippex IV bag, REVIV, Braun Melsungen AG, The IV Doc Inc., Terumo Medical Corporation, Grifols S.A., Harpal Clinic Ltd., Fosmo Med, Core IV Therapy LLC, Cryojuvenate UK Ltd., Hospira, Teleflex Incorporated, Sichuan Kelun Pharmaceutical Co.Ltd., ICU Medical Inc., Vygon SAS, Vifor Pharma Management AG.

North America was the largest region in the intravenous (IV) hydration therapy market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the intravenous (iv) hydration therapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the intravenous (iv) hydration therapy market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.

The intravenous (IV) hydration therapy market includes revenues earned by entities by providing normal saline, half-normal saline, lactated ringers, dextrose, and related detoxification. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Intravenous (IV) Hydration Therapy Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on intravenous (iv) hydration therapy market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for intravenous (iv) hydration therapy ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The intravenous (iv) hydration therapy market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of covid 19 on supply chains and consumption patterns.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

  • 1) By Service: Immune Boosters; Energy Boosters; Skin Care; Migraine; Other Service
  • 2) By Component: Medicated; Non-Medicated
  • 3) By End-User: Hospitals And Clinics; Wellness Centers And Spas; Home Healthcare; Other End-Users
  • Companies Mentioned: Revitalist; JW Life Science Corporation; NextGen Healthcare; B. Braun Medical Inc.; Pfizer Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Intravenous (IV) Hydration Therapy Market Characteristics

3. Intravenous (IV) Hydration Therapy Market Trends And Strategies

4. Intravenous (IV) Hydration Therapy Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Intravenous (IV) Hydration Therapy Market Size and Growth

  • 5.1. Global Intravenous (IV) Hydration Therapy Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Intravenous (IV) Hydration Therapy Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Intravenous (IV) Hydration Therapy Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Intravenous (IV) Hydration Therapy Market Segmentation

  • 6.1. Global Intravenous (IV) Hydration Therapy Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Immune Boosters
  • Energy Boosters
  • Skin Care
  • Migraine
  • Other Service
  • 6.2. Global Intravenous (IV) Hydration Therapy Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Medicated
  • Non-Medicated
  • 6.3. Global Intravenous (IV) Hydration Therapy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Hospitals And Clinics
  • Wellness Centers And Spas
  • Home Healthcare
  • Other End-Users

7. Intravenous (IV) Hydration Therapy Market Regional And Country Analysis

  • 7.1. Global Intravenous (IV) Hydration Therapy Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Intravenous (IV) Hydration Therapy Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Intravenous (IV) Hydration Therapy Market

  • 8.1. Asia-Pacific Intravenous (IV) Hydration Therapy Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Intravenous (IV) Hydration Therapy Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Intravenous (IV) Hydration Therapy Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Intravenous (IV) Hydration Therapy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Intravenous (IV) Hydration Therapy Market

  • 9.1. China Intravenous (IV) Hydration Therapy Market Overview
  • 9.2. China Intravenous (IV) Hydration Therapy Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Intravenous (IV) Hydration Therapy Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Intravenous (IV) Hydration Therapy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Intravenous (IV) Hydration Therapy Market

  • 10.1. India Intravenous (IV) Hydration Therapy Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Intravenous (IV) Hydration Therapy Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Intravenous (IV) Hydration Therapy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Intravenous (IV) Hydration Therapy Market

  • 11.1. Japan Intravenous (IV) Hydration Therapy Market Overview
  • 11.2. Japan Intravenous (IV) Hydration Therapy Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Intravenous (IV) Hydration Therapy Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Intravenous (IV) Hydration Therapy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Intravenous (IV) Hydration Therapy Market

  • 12.1. Australia Intravenous (IV) Hydration Therapy Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Intravenous (IV) Hydration Therapy Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Intravenous (IV) Hydration Therapy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Intravenous (IV) Hydration Therapy Market

  • 13.1. Indonesia Intravenous (IV) Hydration Therapy Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Intravenous (IV) Hydration Therapy Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Intravenous (IV) Hydration Therapy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Intravenous (IV) Hydration Therapy Market

  • 14.1. South Korea Intravenous (IV) Hydration Therapy Market Overview
  • 14.2. South Korea Intravenous (IV) Hydration Therapy Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Intravenous (IV) Hydration Therapy Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Intravenous (IV) Hydration Therapy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Intravenous (IV) Hydration Therapy Market

  • 15.1. Western Europe Intravenous (IV) Hydration Therapy Market Overview
  • 15.2. Western Europe Intravenous (IV) Hydration Therapy Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Intravenous (IV) Hydration Therapy Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Intravenous (IV) Hydration Therapy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Intravenous (IV) Hydration Therapy Market

  • 16.1. UK Intravenous (IV) Hydration Therapy Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Intravenous (IV) Hydration Therapy Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Intravenous (IV) Hydration Therapy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Intravenous (IV) Hydration Therapy Market

  • 17.1. Germany Intravenous (IV) Hydration Therapy Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Intravenous (IV) Hydration Therapy Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Intravenous (IV) Hydration Therapy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Intravenous (IV) Hydration Therapy Market

  • 18.1. France Intravenous (IV) Hydration Therapy Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Intravenous (IV) Hydration Therapy Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Intravenous (IV) Hydration Therapy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Intravenous (IV) Hydration Therapy Market

  • 19.1. Italy Intravenous (IV) Hydration Therapy Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Intravenous (IV) Hydration Therapy Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Intravenous (IV) Hydration Therapy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Intravenous (IV) Hydration Therapy Market

  • 20.1. Spain Intravenous (IV) Hydration Therapy Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Intravenous (IV) Hydration Therapy Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Intravenous (IV) Hydration Therapy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Intravenous (IV) Hydration Therapy Market

  • 21.1. Eastern Europe Intravenous (IV) Hydration Therapy Market Overview
  • 21.2. Eastern Europe Intravenous (IV) Hydration Therapy Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Intravenous (IV) Hydration Therapy Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Intravenous (IV) Hydration Therapy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Intravenous (IV) Hydration Therapy Market

  • 22.1. Russia Intravenous (IV) Hydration Therapy Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Intravenous (IV) Hydration Therapy Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Intravenous (IV) Hydration Therapy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Intravenous (IV) Hydration Therapy Market

  • 23.1. North America Intravenous (IV) Hydration Therapy Market Overview
  • 23.2. North America Intravenous (IV) Hydration Therapy Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Intravenous (IV) Hydration Therapy Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Intravenous (IV) Hydration Therapy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Intravenous (IV) Hydration Therapy Market

  • 24.1. USA Intravenous (IV) Hydration Therapy Market Overview
  • 24.2. USA Intravenous (IV) Hydration Therapy Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Intravenous (IV) Hydration Therapy Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Intravenous (IV) Hydration Therapy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Intravenous (IV) Hydration Therapy Market

  • 25.1. Canada Intravenous (IV) Hydration Therapy Market Overview
  • 25.2. Canada Intravenous (IV) Hydration Therapy Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Intravenous (IV) Hydration Therapy Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Intravenous (IV) Hydration Therapy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Intravenous (IV) Hydration Therapy Market

  • 26.1. South America Intravenous (IV) Hydration Therapy Market Overview
  • 26.2. South America Intravenous (IV) Hydration Therapy Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Intravenous (IV) Hydration Therapy Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Intravenous (IV) Hydration Therapy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Intravenous (IV) Hydration Therapy Market

  • 27.1. Brazil Intravenous (IV) Hydration Therapy Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Intravenous (IV) Hydration Therapy Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Intravenous (IV) Hydration Therapy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Intravenous (IV) Hydration Therapy Market

  • 28.1. Middle East Intravenous (IV) Hydration Therapy Market Overview
  • 28.2. Middle East Intravenous (IV) Hydration Therapy Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Intravenous (IV) Hydration Therapy Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Intravenous (IV) Hydration Therapy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Intravenous (IV) Hydration Therapy Market

  • 29.1. Africa Intravenous (IV) Hydration Therapy Market Overview
  • 29.2. Africa Intravenous (IV) Hydration Therapy Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Intravenous (IV) Hydration Therapy Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Intravenous (IV) Hydration Therapy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Intravenous (IV) Hydration Therapy Market Competitive Landscape And Company Profiles

  • 30.1. Intravenous (IV) Hydration Therapy Market Competitive Landscape
  • 30.2. Intravenous (IV) Hydration Therapy Market Company Profiles
    • 30.2.1. Revitalist
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. JW Life Science Corporation
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. NextGen Healthcare
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. B. Braun Medical Inc.
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. Pfizer Inc.
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Intravenous (IV) Hydration Therapy Market Other Major And Innovative Companies

  • 31.1. Fresenius Kabi AG
  • 31.2. Liquid IV
  • 31.3. Medtronic Plc.
  • 31.4. Drip Hydration
  • 31.5. Amanta Healthcare Ltd.
  • 31.6. Becton Dickinson and Company
  • 31.7. Elixir
  • 31.8. Baxter International Inc.
  • 31.9. Otsuka Pharmaceutical Co. Ltd.
  • 31.10. Sippex IV bag
  • 31.11. REVIV
  • 31.12. Braun Melsungen AG
  • 31.13. The IV Doc Inc.
  • 31.14. Terumo Medical Corporation
  • 31.15. Grifols S.A.

32. Global Intravenous (IV) Hydration Therapy Market Competitive Benchmarking

33. Global Intravenous (IV) Hydration Therapy Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Intravenous (IV) Hydration Therapy Market

35. Intravenous (IV) Hydration Therapy Market Future Outlook and Potential Analysis

  • 35.1 Intravenous (IV) Hydration Therapy Market In 2028 - Countries Offering Most New Opportunities
  • 35.2 Intravenous (IV) Hydration Therapy Market In 2028 - Segments Offering Most New Opportunities
  • 35.3 Intravenous (IV) Hydration Therapy Market In 2028 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer